Transamerica Financial Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Buy
216
+178
+468% +$15.1K ﹤0.01% 902
2026
Q1
$3.27K Buy
38
+19
+100% +$1.71K ﹤0.01% 1117
2025
Q4
$1.66K Sell
19
-3
-14% -$228 ﹤0.01% 1166
2025
Q3
$1.26K Buy
+22
New +$1.27K ﹤0.01% 1135

Other funds holding GMED

Transamerica Financial Advisors's GMED Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Globus Medical (GMED) stake by 468% in Q2 2026, buying an estimated $15.1K and bringing the position to 216 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Transamerica Financial Advisors first reported a position in GMED in Q3 2025 and has held it in 4 quarters since. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Transamerica Financial Advisors held 216 shares of Globus Medical worth $17.1K as of Q2 2026.
  • Transamerica Financial Advisors bought 178 Globus Medical shares in Q2 2026, an estimated $15.1K.
  • Globus Medical made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #902 holding.
  • Transamerica Financial Advisors first reported a position in Globus Medical in Q3 2025 and has held it in 4 quarters since.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.